Preparing for the US Biosecure Act - what does it mean for the pharma industry?

The US Biosecure Act was passed by the House of Representatives in September and seems likely to become law. The Biosecure Act was first proposed by the US government late last year due to concerns about national security and how genetic and other biological data could be misused by foreign adversarial governments, with a focus on China.